BTIG Research Initiates Coverage on Ardelyx (NASDAQ:ARDX)
BTIG Research initiated coverage on shares of Ardelyx (NASDAQ:ARDX – Free Report) in a report released on Tuesday morning, MarketBeat reports. The firm issued a buy rating and a $14.00 target price on the biopharmaceutical company’s stock. A number of other equities analysts also recently commented on ARDX. Piper Sandler lifted their target price on […]
BTIG Research initiated coverage on shares of Ardelyx (NASDAQ:ARDX – Free Report) in a report released on Tuesday morning, MarketBeat reports. The firm issued a buy rating and a $14.00 target price on the biopharmaceutical company’s stock. A number of other equities analysts also recently commented on ARDX. Piper Sandler lifted their target price on […]
